Mesoporous carbon@silicon-silica nanotheranostics for synchronous delivery of insoluble drugs and luminescence imaging

Biomaterials

Volumn 33, Issue 17, 2012, Pages 4392-4402

  He, Qianjun ^a   Ma, Ming ^a   Wei, Chenyang ^a   Shi, Jianlin ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

Author keywords

Drug delivery; Hierarchical nanostructures; Luminescence imaging; Mesoporous silica; Nanoparticle; Theranostic nanomedicine

Indexed keywords

CANCER CELLS; DISPERSIVITY; HIERARCHICAL NANOSTRUCTURES; HYALURONIC ACIDS; IN-SITU; INSOLUBLE DRUG; LUMINESCENCE IMAGING; MESO-PORES; MESOPOROUS CARBON; MESOPOROUS SILICA; MESOPOROUS SILICA NANOPARTICLES; NANOMEDICINES; NARROW SIZE DISTRIBUTIONS; SI NANOCRYSTAL; THERANOSTICS;

DRUG DELIVERY; INFRARED DEVICES; MEDICAL NANOTECHNOLOGY; NANOSTRUCTURES; ORGANIC ACIDS; PHOSPHOLIPIDS; SILICA;

LUMINESCENCE;

CAMPTOTHECIN; CARBON; HERMES ANTIGEN; HYALURONIC ACID; NANOCARRIER; NANOCRYSTAL; PHOSPHOLIPID; SILICON; SILICON DIOXIDE;

ADSORPTION; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARBONIZATION; CHEMICAL REACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CRYSTALLIZATION; DESORPTION; DISPERSION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFRARED RADIATION; LUMINESCENCE; NANOENCAPSULATION; NANOFABRICATION; PARTICLE SIZE; PRIORITY JOURNAL; TARGET CELL;

ADSORPTION; ANIMALS; CAMPTOTHECIN; CELL DEATH; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; HUMANS; HYALURONIC ACID; LUMINESCENCE; MICE; NANOMEDICINE; NANOPARTICLES; NITROGEN; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POROSITY; SCATTERING, SMALL ANGLE; SILICON; SILICON DIOXIDE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTROSCOPY, NEAR-INFRARED; SPECTRUM ANALYSIS, RAMAN; TEMPERATURE; X-RAY DIFFRACTION;

EID: 84858865635     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.02.056     Document Type: Article

References (54)

1. Sun D.X. Nanotheranostics: integration of imaging and targeted drug delivery. Mol Pharm 2010, 7:1879.
2. Bae K.H., Chung H.J., Park T.G. Nanomaterials for cancer therapy and imaging. Mol Cells 2011, 31:295-302.
3. Xie J., Lee S., Chen X.Y. Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 2010, 62:1064-1079.
4. Kim J., Piao Y., Hyeon T. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem Soc Rev 2009, 38:372-390.
5. Ambrogio M.W., Thomas C.R., Zhao Y.L., Zink J.I., Stoddart J.F. Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine. Acc Chem Res 2011, 44:903-913.
6. He Q.J., Shi J.L. Mesoporous silica nanoparticles based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J Mater Chem 2011, 21:5845-5855.
7. Kim J., Kim H.S., Lee N., Kim T., Kim H., Yu T., et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Edit 2008, 47:8438-8441.
8. Kim J., Lee J.E., Lee J., Yu J.H., Kim B.C., An K., et al. Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J Am Chem Soc 2006, 128:688-689.
9. Taylor K.M.L., Kim J.S., Rieter W.J., An H.Y., Lin W.L., Lin W.B. Mesoporous silica nanospheres as highly efficient MRI contrast agents. J Am Chem Soc 2008, 130:2154-2155.
10. Lin Y.S., Wu S.H., Hung Y., Chou Y.H., Chang C., Lin M.L., et al. Multifunctional composite nanoparticles: magnetic, luminescent, and mesoporous. Chem Mater 2006, 18:5170-5172.
11. Hu X.G., Zrazhevskiy P., Gao X.H. Encapsulation of single quantum dots with mesoporous silica. Ann Biomed Eng 2009, 37:1960-1966.
12. 3:Yb, Er core/mesoporous silica shell structure. Eur J Inorg Chem 2010, 33:5195-5199.
13. Yang P.P., Quan Z.W., Hou Z.Y., Li C.X., Kang X.J., Cheng Z.Y., et al. A magnetic, luminescent and mesoporous core-shell structured composite material as drug carrier. Biomaterials 2009, 30:4786-4795.
14. Wang C., Tao H.Q., Cheng L., Liu Z. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials 2011, 32:6145-6154.
15. Xu H., Cheng L., Wang C., Ma X.X., Li Y.G., Liu Z. Polymer encapsulated upconversion nanoparticle/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug delivery. Biomaterials 2011, 32:9364-9373. http://www.sciencedirect.com/science/article/pii/S0142961211010015.
16. Wang C., Cheng L., Liu Z. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials 2011, 32:1110-1120.
17. Xing H.Y., Bu W.B., Zhang S.J., Zheng X.P., Li M., Chen F., et al. Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials 2012, 33:1079-1089.
18. Zhou J., Liu Z., Li F.Y. Upconversion nanophosphors for small-animal imaging. Chem Soc Rev 2012, 41:1323-1349.
19. Erogbogbo F., Yong K.T., Roy I., Xu G.X., Prasad P.N., Swihart M.T. Biocompatible luminescent silicon quantum dots for imaging of cancer cells. ACS Nano 2008, 2:873-878.
20. Tu C.Q., Ma X.C., Pantazis P., Kauzlarich S.M., Louie A.Y. Paramagnetic, silicon quantum dots for magnetic resonance and two photon imaging of macrophages. J Am Chem Soc 2010, 132:2016-2023.
21. He G.S., Zheng Q.D., Yong K.T., Erogbogbo F., Swihart M.T., Prasad P.N. Two- and three-photon absorption and frequency upconverted emission of silicon quantum dots. Nano Lett 2008, 8:2688-2692.
22. Brigger I., Dubernet C., Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 2002, 54:631-651.
23. Rosenholm J.M., Meinander A., Peulhu E., Niemi R., Eriksson J.E., Sahlgren C., et al. Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 2009, 3:197-206.
24. Lebret V., Raehm L., Durand J.O., Smaihi M., Werts M.H.V., Blanchard-Desce M., et al. Folic acid-targeted mesoporous silica nanoparticles for two-photon fluorescence. J Biomed Nanotechnol 2010, 6:176-180.
25. Tsai C.P., Chen C.Y., Hung Y., Chang F.H., Mou C.Y. Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells. J Mater Chem 2009, 19:5737-5743.
26. Brevet D., Bobo M.G., Raehm L., Richeter S., Hocine O., Amro K., et al. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Chem Commun 2009, 12:1475-1477.
27. Wells A.S. On the perils of unexpected silane generation. Org Process Res Dev 2010, 14:484.
28. 2+ adsorbents. J Mater Chem 2008, 18:2733-2738.
29. He Q.J., Shi J.L., Cui X.Z., Wei C.Y., Zhang L.X., Wu W., et al. Synthesis of oxygen-deficient luminescent mesoporous silica nanoparticles for synchronous drug delivery and imaging. Chem Commun 2011, 47:7947-7949.
30. Kim H., Cho J. Superior lithium electroactive mesoporous Si@carbon core-shell nanowires for lithium battery anode material. Nano Lett 2008, 8:3688-3691.
31. Li Y.S., Ba A. Spectroscopic studies of triethoxysilane sol-gel and coating process. Spectrochim Acta Part A 2008, 70:1013-1019.
32. Vella E., Buscarino G., Vaccaro G., Boscaino R. Structural organization of silanol and silicon hydride groups in the amorphous silicon dioxide network. Eur Phys J B 2011, 83:47-52.
33. 2 composites and freestanding hydride-surface-terminated silicon nanoparticles. Chem Mater 2006, 18:6139-6146.
34. Cohen Y., Hatton B., Míguez H., Coombs N., Fournier-Bidoz S., Grey J., et al. Spin-on nanostructured silicon-silica film displaying room-temperature nanosecond lifetime photoluminescence. Adv Mater 2003, 15:572-576.
35. Cohen Y., Landskron K., Tétreault N., Fournier-Bidoz S., Hatton B., Ozin G. A silicon-silica nanocomposite material. Adv Funct Mater 2005, 15:593-602.
36. Lu J., Liong M., Zink J.I., Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 2007, 3:1341-1346.
37. Lu J., Liong M., Li Z.X., Zink J.I., Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 2010, 6:1794-1805.
38. He Q.J., Gao Y., Zhang L.X., Bu W.B., Chen H.R., Li Y.P., et al. One-pot self-assembly of mesoporous silica nanoparticle-based pH-responsive anti-cancer nano drug delivery system. J Mater Chem 2011, 21:15190-15192.
39. Liu Z., Robinson J.T., Sun X.M., Dai H.J. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc 2008, 130:10876-10877.
40. Cauvel A., Brunel D., Renzo F.D., Garrone E., Fubini B. Hydrophobic and hydrophilic behavior of micelle-templated mesoporous silica. Langmuir 1997, 13:2773-2778.
41. Belomoin G., Therrien J., Smith A., Rao S., Twesten R., Chaieb S., et al. Observation of a magic discrete family of ultrabright Si nanoparticles. Appl Phys Lett 2002, 80:841-843.
42. Zou J., Baldwin R.K., Pettigrew K.A., Kauzlarich S.M. Solution synthesis of ultrastable luminescent siloxane-coated silicon nanoparticles. Nano Lett 2004, 4:1181-1186.
43. Kumar R., Roy I., Ohulchanskyy T.Y., Goswami L.N., Bonoiu A.C., Bergey E.J., et al. Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. ACS Nano 2008, 2:449-456.
44. He Q.J., Zhang J.M., Shi J.L., Zhu Z.Y., Zhang L.X., Bu W.B., et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 2010, 31:1085-1092.
45. Liu Z., Tabakman S.M., Chen Z., Dai H.J. Preparation of carbon nanotube bioconjugates for biomedical applications. Nat Protoc 2009, 4:1372-1381.
46. Liu J.W., Stace-Naughton A., Jiang X.M., Brinker C.J. Porous nanoparticle supported lipid bilayers (Protocells) as delivery. J Am Chem Soc 2009, 131:1354-1355.
47. Wang L.S., Wu L.C., Lu S.Y., Chang L.L., Teng I.T., Yang C.M., et al. Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery: improved water suspensibility and decreased nonspecific protein binding. ACS Nano 2010, 4:4371-4379.
48. Ashley C.E., Carnes E.C., Phillips G.K., Padilla D., Durfee P.N., Brown P.A., et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater 2011, 10:476.
49. Knudson W. Tumor-associated hyaluronan: providing an extracellular matrix that facilitates invasion. Am J Pathol 1996, 148:1721-1726.
50. Choi K.Y., Min K.H., Yoon H.Y., Kim K., Park J.H., Kwon I.C., et al. PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Biomaterials 2011, 32:1880-1889.
51. Ossipov D.A. Nanostructured hyaluronic acid-based materials for active delivery to cancer. Expert Opin Drug Del 2010, 7:681-703.
52. Kim K.S., Hur W., Park S.J., Hong S.W., Choi J.E., Goh E.J., et al. Bioimaging for targeted delivery of hyaluronic acid derivatives to the livers in cirrhotic mice using quantum dots. ACS Nano 2010, 4:3005-3014.
53. Afify A., Purnell P., Nguyen L. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Exp Mol Pathol 2009, 86:95-100.
54. Katagiri Y.U., Sleeman J., Fujii H., Herrlich P., Hotta H., Tanaka K., et al. CD44 variants but not CD44s cooperate with b1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res 1999, 59:219-226.